Changes in Vascular Distensibility during Angiotensin-Converting Enzyme Inhibition Involve Bradykinin Type 2 Receptors

Publisher： Karger

E-ISSN： 1423-0135|41|1|18-27

ISSN： 1018-1172

Source： Journal of Vascular Research, Vol.41, Iss.1, 2004-02, pp. : 18-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sarcopenia – A Potential Target for Angiotensin-Converting Enzyme Inhibition?

By  

Gerontology, Vol. 52, Iss. 4, 2006-07 ,pp. : 237-242

Karger

Access to resources Recommend Favorite

Human Vascular Reactivity and Polymorphisms of the Angiotensin-Converting Enzyme and the Angiotensin Type 1 Receptor Genes

By  

Journal of Vascular Research, Vol. 36, Iss. 6, 1999-12 ,pp. : 445-455

Karger

Access to resources Recommend Favorite

Systemic vascular resistance during brief withdrawal of angiotensin converting enzyme inhibition in heart failure

By Gabrielsen A.   Bie P.   Christensen N.   Frandsen E.   Galatius S.   Pump B.   Sørensen V. B.   Kastrup J.   Norsk P.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 62, Iss. 4, 2002-06 ,pp. : 245-254

Informa Healthcare

Access to resources Recommend Favorite

The Changes of Serum Angiotensin-Converting Enzyme 2 in Patients with Pulmonary Arterial Hypertension due to Congenital Heart Disease

By  

Cardiology, Vol. 124, Iss. 4, 2013-03 ,pp. : 208-212

Karger

Access to resources Recommend Favorite

NO-Dependent Endothelial Dysfunction in Type II Diabetes Is Aggravated by Dyslipidemia and Hypertension, but Can Be Restored by Angiotensin-Converting Enzyme Inhibition and Weight Loss

By  

Journal of Vascular Research, Vol. 50, Iss. 6, 2013-10 ,pp. : 486-497

Karger

Access to resources Recommend Favorite